Candriam S.C.A. Pfizer Inc Transaction History

Candriam S.C.A.

$16.9 Billion
Q4 2024

A detailed history of Candriam S.C.A. transactions in Pfizer Inc stock. As of the latest transaction made, Candriam S.C.A. holds 422,501 shares of PFE stock, worth $10.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

422,501

Previous 392,294 7.7%

Holding current value

$10.9 Million

Previous $11.4 Million 1.27%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$24.8 - $30.19 $749,133 - $911,949	30,207 Added 7.7%	422,501 $11.2 Million
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $10.6 Million - $12 Million	-383,303 Reduced 49.42%	392,294 $11.4 Million
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $13.5 Million - $15.8 Million	-532,565 Reduced 40.71%	775,597 $21.7 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $11 Million - $12.7 Million	426,371 Added 48.35%	1,308,162 $36.3 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $4.7 Million - $6.11 Million	180,002 Added 25.65%	881,791 $25.4 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $920,180 - $1.08 Million	28,675 Added 4.26%	701,789 $23.3 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $24.9 Million - $28.9 Million	-690,431 Reduced 50.63%	673,114 $24.7 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $1.1 Million - $1.44 Million	28,007 Added 2.1%	1,363,545 $55.6 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $4.2 Million - $5.48 Million	-100,587 Reduced 7.0%	1,335,538 $68.5 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $28.2 Million - $34.4 Million	644,675 Added 81.45%	1,436,125 $62.8 Million
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $17.8 Million - $21.1 Million	382,709 Added 93.63%	791,450 $41.5 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $1.57 Million - $1.95 Million	-34,336 Reduced 7.75%	408,741 $21.2 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $12.8 Million - $18.9 Million	309,129 Added 230.78%	443,077 $26.2 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $358,077 - $459,981	9,123 Added 7.31%	133,948 $5.76 Million
Q2 2021 Jul 20, 2021	SELL	$35.91 - $40.68 $893,045 - $1.01 Million	-24,869 Reduced 16.61%	124,825 $4.89 Million
Q4 2020 Jan 22, 2021	SELL	$33.47 - $42.56 $931,503 - $1.18 Million	-27,831 Reduced 15.68%	149,694 $5.5 Million
Q3 2020 Oct 19, 2020	BUY	$31.75 - $37.25 $335,184 - $393,248	10,557 Added 6.32%	177,525 $6.52 Million
Q2 2020 Jul 23, 2020	SELL	$30.12 - $36.54 $10.3 Million - $12.5 Million	-341,854 Reduced 67.19%	166,968 $5.46 Million
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $6.43 Million - $7.29 Million	195,218 Added 62.25%	508,822 $20,000
Q3 2019 Oct 21, 2019	SELL	$32.49 - $42.13 $1.1 Million - $1.42 Million	-33,712 Reduced 9.71%	313,604 $11,000
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $1.91 Million - $2.14 Million	-51,659 Reduced 12.95%	347,316 $15 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $2.07 Million - $2.27 Million	-55,073 Reduced 12.13%	398,975 $16.9 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $3.27 Million - $3.72 Million	-84,900 Reduced 15.75%	454,048 $19.8 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $1.55 Million - $1.88 Million	-44,974 Reduced 7.7%	538,948 $23.8 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $6.76 Million - $7.2 Million	-204,858 Reduced 25.97%	583,922 $21.2 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $1.89 Million - $2.19 Million	59,146 Added 8.11%	788,780 $28 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $445,318 - $472,497	13,389 Added 1.87%	729,634 $26.4 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $22.2 Million - $24.5 Million	716,245	716,245 $25.6 Million

Others Institutions Holding PFE

# of Institutions

3,350

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account